IVAFARM, OOO, Moscow Oblast

Economic indicators

Net profit (RAS) of IVAFARM, OOO grew over 2023 2.11 times to 537.00 thousand RUB from 255.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 20.89% to 15.81 million RUB from 13.08 million RUB over 2022; cost of goods sold grew by 25.72% to 13.95 million RUB from 11.10 million RUB; sales profit went up 1.54 times to 998.00 thousand RUB from 646.00 thousand RUB.

Net profit (RAS) of IVAFARM, OOO grew over 2022 by 12.33% to 255.00 thousand RUB from 227.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 14.40% to 13.08 million RUB from 15.28 million RUB in 2021; cost of goods sold decreased by 19.44% to 11.10 million RUB from 13.77 million RUB; sales profit went up by 18.10% to 646.00 thousand RUB from 547.00 thousand RUB.

Net profit (RAS) of IVAFARM, OOO made up 227.00 thousand RUB over 2021 compared to net loss of 863.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period 4.98 times to 15.28 million RUB from 3.07 million RUB over 2020; cost of goods sold grew 6.03 times to 13.77 million RUB from 2.28 million RUB; sales profit made up 547.00 thousand RUB compared to sales loss of 751.00 thousand RUB.

Net loss (RAS) of IVAFARM, OOO increased 287.67 times to 863.00 thousand RUB from 3.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period 3.52 times to 3.07 million RUB from 10.80 million RUB in 2019; cost of goods sold decreased 3.56 times to 2.28 million RUB from 8.12 million RUB; sales loss made up 751.00 thousand RUB compared to sales profit of 510.00 thousand RUB.

Companies in the region

• MIAMIT
• AL'FATEKHFORM
• MARS14
• RANFER
• SIBUYA